Articles By 'Tim Shannon'

Vivace's VT3989 Enters Phase 3: A New Hope for Mesothelioma Patients

A milestone in targeted oncology and looking ahead

Tim Shannon: More hope for cystic fibrosis treatment, and still more to do

Tim Shannon: Durable bonds and the birth of Vivace Therapeutics